These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32741828)

  • 1. Escitalopram Alleviates Alzheimer's Disease-Type Tau Pathologies in the Aged P301L Tau Transgenic Mice.
    Wang YJ; Gong WG; Ren QG; Zhang ZJ
    J Alzheimers Dis; 2020; 77(2):807-819. PubMed ID: 32741828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.
    Wang YJ; Ren QG; Gong WG; Wu D; Tang X; Li XL; Wu FF; Bai F; Xu L; Zhang ZJ
    Oncotarget; 2016 Mar; 7(12):13328-39. PubMed ID: 26950279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram alleviates stress-induced Alzheimer's disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity.
    Wu C; Gong WG; Wang YJ; Sun JJ; Zhou H; Zhang ZJ; Ren QG
    Neurobiol Aging; 2018 Jul; 67():137-147. PubMed ID: 29656013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram Ameliorates Tau Hyperphosphorylation and Spatial Memory Deficits Induced by Protein Kinase A Activation in Sprague Dawley Rats.
    Ren QG; Wang YJ; Gong WG; Xu L; Zhang ZJ
    J Alzheimers Dis; 2015; 47(1):61-71. PubMed ID: 26402755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.
    Xiong J; Deng I; Kelliny S; Lin L; Bobrovskaya L; Zhou XF
    Metab Brain Dis; 2022 Aug; 37(6):1941-1957. PubMed ID: 35704147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.
    Ren QG; Wang YJ; Gong WG; Zhou QD; Xu L; Zhang ZJ
    J Mol Neurosci; 2015 Jun; 56(2):500-8. PubMed ID: 25687330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.
    Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y
    J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
    J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model.
    Mañucat-Tan NB; Shen LL; Bobrovskaya L; Al-Hawwas M; Zhou FH; Wang YJ; Zhou XF
    Aging (Albany NY); 2019 Sep; 11(17):6762-6791. PubMed ID: 31479419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.
    Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ
    CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
    Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
    Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.
    Melchior B; Mittapalli GK; Lai C; Duong-Polk K; Stewart J; Güner B; Hofilena B; Tjitro A; Anderson SD; Herman DS; Dellamary L; Swearingen CJ; Sunil KC; Yazici Y
    Aging Cell; 2019 Oct; 18(5):e13000. PubMed ID: 31267651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice.
    Huang HJ; Chen SL; Huang HY; Sun YC; Lee GC; Lee-Chen GJ; Hsieh-Li HM; Su MT
    Psychopharmacology (Berl); 2019 Feb; 236(2):763-773. PubMed ID: 30426182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.
    von Linstow CU; Waider J; Grebing M; Metaxas A; Lesch KP; Finsen B
    Alzheimers Res Ther; 2017 Sep; 9(1):74. PubMed ID: 28899417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.
    Fine JM; Baillargeon AM; Renner DB; Hoerster NS; Tokarev J; Colton S; Pelleg A; Andrews A; Sparley KA; Krogh KM; Frey WH; Hanson LR
    Exp Brain Res; 2012 Jun; 219(3):381-90. PubMed ID: 22547371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.